Pure Global Cannabis Inc Stock Toronto S.E.
Equities
RSL
CA7806782073
Pharmaceuticals
Sales 2017 | - | Sales 2018 | - | Capitalization | 24.16M 32.98M |
---|---|---|---|---|---|
Net income 2017 | - 0 | Net income 2018 | -23M -31.4M | EV / Sales 2017 * | - |
Net Debt 2017 | 211K 288K | Net Debt 2018 | 4.49M 6.13M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-0.72
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 83.64% |
Managers | Title | Age | Since |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 18-07-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 18-06-30 |
1st Jan change | Capi. | |
---|---|---|
+43.31% | 6.19B | |
-16.99% | 4.48B | |
+6.39% | 3.29B | |
-13.10% | 3.12B | |
-4.17% | 2.5B | |
+45.47% | 1.94B | |
-9.11% | 1.68B | |
-2.09% | 1.64B | |
-12.50% | 1.56B |